Direct-to-consumer drugs are transforming patient access to GLP-1 therapies, but hidden costs and coordination hurdles raise policy concerns for regulators.
New hypertension drugs like baxdrostat and lorundrostat are expensive and barely lower blood pressure more than generic drugs,…
Discover how noninvasive imaging technologies like OCT and RCM can replace biopsies for diagnosing basal cell carcinoma, according…
Learn why user access was blocked after a pharmacy policy breach and how strategic leadership can prevent future…
Discover why web access blocks are reported across the internet and how these disruptions impact global digital connectivity…
Direct-to-consumer drugs are transforming patient access to GLP-1 therapies, but hidden costs and coordination hurdles raise policy concerns…
Pharmacy benefit managers face new transparency rules under the 2026 federal law, reshaping drug negotiations and access for…
Early childhood may hold critical clues to reducing ADHD risk. Researchers track developmental risks from pregnancy through toddlerhood.
The 2026 cholesterol guideline expands therapy eligibility to over half of U.S. adults, highlighting new risk thresholds and…
Sleep deprivation can lead to decreased cognitive function and impaired motor skills, affecting individuals who work in high-pressure…
Narcolepsy treatment breakthrough as FDA approves Takeda's oral drug Orzeyful, offering the first therapy to target all type…
